Pharvaris (PHVS) EPS (Weighted Average and Diluted) (2023 - 2025)
Pharvaris (PHVS) reported EPS (Weighted Average and Diluted) of $27227.3 for Q2 2025, down 1.94% on a YoY basis from $27766.3 in Q2 2024, and down 1.94% quarter-over-quarter from $27766.3 in Q2 2024.
Pharvaris (PHVS) EPS (Weighted Average and Diluted) (2023 - 2025) Analysis & Trends
Pharvaris has reported EPS (Weighted Average and Diluted) for 3 years, with the latest figure at $27227.3 in Q2 2025.
- For the quarter ending Q2 2025, EPS (Weighted Average and Diluted) fell 1.94% year-over-year to $27227.3; the trailing twelve-month figure through Jun 2025 stood at $27227.3 (down 1.94% YoY), and the FY2025 full-year result was -$3.36, down 25.01% from the prior year.
- EPS (Weighted Average and Diluted) for Q2 2025 stood at $27227.3, down from $27766.3 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $27766.3 in Q2 2024, with the low at $16843.3 in Q2 2023.
- Historically, EPS (Weighted Average and Diluted) has averaged $23945.6 across 3 years, with a median of $27227.3 in 2025.
- Annual changes were most pronounced in 2024 — EPS (Weighted Average and Diluted) surged 64.85% — and 2025, when it decreased 1.94%.
- Pharvaris' EPS (Weighted Average and Diluted) stood at $16843.3 in 2023, then surged by 64.85% to $27766.3 in 2024, then dropped by 1.94% to $27227.3 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at $27227.3 (Q2 2025), $27766.3 (Q2 2024), and $16843.3 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 0.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -0.61 |
| 10 | Pharvaris | 28.66 Bn | 28.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 27,227.29 |
| Jun 30, 2024 | 27,766.32 |
| Jun 30, 2023 | 16,843.27 |